Patient-targeted education (ePRO-E) to increase ePRO intent within an Alliance clinical trial (A221805-SI1) is a research paper published in JNCI Cancer Spectrum (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA235726
NCI NIH HHS
Grant: UG1 CA233160
NCI NIH HHS
Grant: UG1 CA189823
National Institutes of Health
Grant: 5UG1CA189823-04
Alliance NCORP Research Base
National Institutes of Health
Grant: 5R01CA235726-03
Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Bind, Placebo-Controlled Phase II to Phase III Study
National Cancer Institute
National Institutes of Health
NIH HHS
FWCI
0.18
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals